[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-335956-105":3,"detail-sidebar-cat-0-en-105":80,"doc-detail-335956-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":73,"head_meta":75,"extra_data":77,"updated_unix":79},105,"en","redening-bioactive-small-molecules-from-microbial-metabolites-as-revolutionary-anticancer-agents","Redeﬁning bioactive small molecules from microbial metabolites as revolutionary anticancer agents","","Cancer treatment remains difficult due to acquired resistance to conventional therapies and toxicities related to treatment. This review examines how microbial-derived secondary metabolites provide biologically active compounds with anticancer potential, summarizing established examples and the mechanisms by which they act on cancer cells. It also surveys emerging metabolite-based therapies, approved treatments, and major drug candidates in clinical trials, highlighting specific molecular targets, as well as challenges in anticancer drug research and development.",{"@graph":14,"@context":72},[15,34,55],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/redening-bioactive-small-molecules-from-microbial-metabolites-as-revolutionary-anticancer-agents/335956/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/redening-bioactive-small-molecules-from-microbial-metabolites-as-revolutionary-anticancer-agents/335956.png","ImageObject",300,407,{"name":42,"@type":43},"Patrick","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-02","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":30},"InteractionCounter",{"@type":54},"ViewAction",{"@type":56,"mainEntity":57},"FAQPage",[58,64,68],{"name":59,"@type":60,"acceptedAnswer":61},"Why does the review focus on microbial metabolites for anticancer therapy?","Question",{"text":62,"@type":63},"Cancer therapy faces challenges such as acquired resistance and adverse toxicities. The review highlights microbial secondary metabolites as a source of diverse biologically active compounds with demonstrated anticancer potential.","Answer",{"name":65,"@type":60,"acceptedAnswer":66},"What distinguishes primary metabolites from secondary metabolites in microbial metabolism?",{"text":67,"@type":63},"Primary metabolites are continuously synthesized and are essential for survival and key cellular processes. Secondary metabolites are not essential for survival, but they provide environmental advantages such as chemical defense or improved resource uptake.",{"name":69,"@type":60,"acceptedAnswer":70},"What does the review cover regarding anticancer compounds derived from microbial metabolites?",{"text":71,"@type":63},"It examines the anticancer mechanisms of established microbial metabolites, discusses emerging therapies derived from these compounds, and reviews approved treatments and major clinical-trial drug candidates with focus on specific molecular targets.","https://schema.org",{"og:url":32,"og:type":74,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":76,"canonical":32},"index,follow",{"doc_id":78,"site_id":7},335956,1790874556,{"code":4,"msg":81,"data":82},"success",[83,87,91,95,100,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":84,"show_sort_weight":85,"slug":86},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":88,"show_sort_weight":89,"slug":90},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":92,"show_sort_weight":93,"slug":94},"Exam",70,"exam",{"id":96,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},5,"Comic",60,"comic",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},6,"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":96,"slug":129},19,"General","general",{"code":4,"msg":81,"data":131},{"doc_id":78,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":30,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":117,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":103,"preview_page_count":4},549758146520,"https://ap-avatar.wpscdn.com/avatar/80002397d8c0411e94?_k=1775819394049821470","Cancer Gene [Therapy](Therapy www.nature.com/cgt)[ www.nature.com/cgt](Therapy www.nature.com/cgt)  \nREVIEW ARTICLE OPEN   \nRedeﬁning bioactive small molecules from microbial metabolites as revolutionary anticancer agents  \nEileena F. Giurini 1, Aishvarya Godla 1 and Kajal H. Gupta 1,2 ✉  \n© The Author(s) 2024  \n\n|  |  |  |\n| --- | --- | --- |\n|  | Cancer treatment remains a signiﬁcant challenge due to issues such as acquired resistance to conventional therapies and the occurrence of adverse treatment-related toxicities. In recent years, researchers have turned their attention to the microbial world in search of novel and effective drugs to combat this devastating disease. Microbial derived secondary metabolites have proven to bea valuable source of biologically active compounds, which exhibit diverse functions and have demonstrated potential as treatments for various human diseases. The exploration of these compounds has provided valuable insights into their mechanisms of action against cancer cells. In-depth studies have been conducted on clinically established microbial metabolites, unraveling their anticancer properties, and shedding light on their therapeutic potential. This review aims to comprehensively examine the anticancer mechanisms of these established microbial metabolites. Additionally, it highlights the emerging therapies derived from these metabolites, offering a glimpse into the immense potential they hold for anticancer drug discovery. Furthermore, this review delves into approved treatments and major drug candidates currently undergoing clinical trials, focusing on speciﬁc molecular targets. It also addresses the challenges and issues encountered in the ﬁeld of anticancer drug research and development. It also presents a comprehensive exposition of the contemporary panorama concerning microbial metabolites serving as a reservoir for anticancer agents, thereby illuminating their auspicious prospects and the prospect of forthcoming strides in the domain of cancer |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  | therapeutics. |  |\n|  |  |  |\n|  |  |  |\n|  | Cancer Gene Therapy (2024) 31:187–206; [https://doi.org/10.1038/s41417-023-00715-x](https://doi.org/10.1038/s41417-023-00715-x) |  |\n|  |  |  |\n\nINTRODUCTION  \nThe use of microorganisms to ﬁnd new drugs for human diseases has been a recurring practice for the past century. Following the discovery of penicillin from Penicillium mold in the 20th century, thousands of bacteria and fungi strains were screened for new antibacterial antibiotics. The impact of these discoveries on humankind has been revolutionary, life expectancy was increased by nearly 30 years in the past century alone [1] . These breakthroughs can be attributed to two factors of microbial world: the sheer abundance of different microbial species, as well as these microorganisms providing a rich source of bioactive compounds that are produced by these organisms. The identiﬁcation of approximately 22,500 bioactive compounds derived from microbes have led to the development of modern therapeutics beyond antibiotics [2] . Further exploration of these promising therapeutic compounds led to the discovery of novel set of bioactive molecules, which possess potential pharmacological properties.  \nMicrobial metabolites comprise two main categories: primary and secondary. Primary metabolites are synthesized continuously, as they are vital for survival and important cellular processes including growth, development, and proliferation [3, 4] . For each of these processes primary metabolites can serve as signaling molecules, catalysts, stimulators, or inhibitors [2] . In contrast, secondary metabolites are not essential for survival or cellular  \nfunction, rather are produced to confer an advantage to the organism in its environment. Secondary metabolites can serve as a chemical defense against environmental","cbCaiu8iyEGKuiiE","https://ap.wps.com/l/cbCaiu8iyEGKuiiE","pdf",2361497,"English","# Introduction\n# Clinically Established Anticancer Microbial Metabolites","[{\"question\":\"Why does the review focus on microbial metabolites for anticancer therapy?\",\"answer\":\"Cancer therapy faces challenges such as acquired resistance and adverse toxicities. The review highlights microbial secondary metabolites as a source of diverse biologically active compounds with demonstrated anticancer potential.\"},{\"question\":\"What distinguishes primary metabolites from secondary metabolites in microbial metabolism?\",\"answer\":\"Primary metabolites are continuously synthesized and are essential for survival and key cellular processes. Secondary metabolites are not essential for survival, but they provide environmental advantages such as chemical defense or improved resource uptake.\"},{\"question\":\"What does the review cover regarding anticancer compounds derived from microbial metabolites?\",\"answer\":\"It examines the anticancer mechanisms of established microbial metabolites, discusses emerging therapies derived from these compounds, and reviews approved treatments and major clinical-trial drug candidates with focus on specific molecular targets.\"}]","Redeﬁning bioactive small molecules from microbial metabolites as revolutionary anticancer agents | PDF",1790012934]